Sponsored by:

Nuclear Medicine: Page 228

Lantheus launches phase III flurpiridaz F-18 trial
By AuntMinnie.com staff writers
Lantheus Medical Imaging has launched the first of two phase III clinical trials of a PET radiopharmaceutical for use in detecting coronary artery disease.
June 29, 2011
PET/CT aids in treatment of neuroblastoma
By AuntMinnie.com staff writers
British researchers are using PET/CT to select children with primary refractory or relapsed high-risk neuroblastoma for treatment with a molecular radiotherapy known as lutetium-177 (Lu-177) DOTATATE, according to a study published in the July issue of the Journal of Nuclear Medicine.
June 29, 2011
Aspect Imaging partners with Cage
By AuntMinnie.com staff writers
Aspect Imaging has signed an agreement with Cage Chemicals to develop and manufacture Aspect's PhenoQuant line of contrast agents for preclinical research.
June 28, 2011
Canadian government to sell AECL
By AuntMinnie.com staff writers
Atomic Energy of Canada (AECL) is about to be sold to SNC-Lavalin Group, according to a June 27 report in the Globe and Mail.
June 28, 2011
Nuclear cardiology reporting falls short
By AuntMinnie.com staff writers
Nuclear cardiology laboratories that participate in the Intersocietal Commission for the Accreditation of Nuclear Medicine Laboratories accreditation process have greater compliance with reporting standards, according to a study published June 19 in the Journal of Nuclear Cardiology.
June 28, 2011
Wildfires prompt Los Alamos closure
By AuntMinnie.com staff writers
The Los Alamos National Laboratory in New Mexico will remain closed for a second day on Tuesday due to nearby wildfires, according to a CNN report.
June 27, 2011
GW receives NCI grant for biomarkers
By AuntMinnie.com staff writers
The U.S. National Cancer Institute (NCI) has awarded a five-year, $500,000-per-year grant to researchers from George Washington University (GW) School of Medicine and Health Sciences.
June 27, 2011
GE launches DaTscan radiotracer in U.S.
By AuntMinnie.com staff writers
GE Healthcare has begun selling its DaTscan (ioflupane I-123 injection) imaging agent to help physicians evaluate patients with suspected Parkinsonian syndromes, such as Parkinson's disease.
June 27, 2011
Treadmill stress tests don't compromise follow-up FDG-PET
By Wayne Forrest
Researchers at Memorial Sloan-Kettering Cancer Center have concluded that a treadmill exercise test before an FDG-PET scan does not increase skeletal muscle FDG uptake and will not adversely affect PET image quality in a clinically significant manner.
June 23, 2011
2011 06 17 17 43 35 704 Molec Insider Thumb
NorthStar picks isotope facility site
By AuntMinnie.com staff writers
NorthStar Medical Radioisotopes has chosen Beloit, WI, as the location to build a $194 million facility to produce medical isotopes from molybdenum-99.
June 22, 2011
Cardium chooses Cedars-Sinai for ASPIRE
By AuntMinnie.com staff writers
Cardium Therapeutics has chosen Cedars-Sinai Medical Center Nuclear Cardiology Core Laboratory in Los Angeles to serve as the central core lab for its Generx ASPIRE clinical study.
June 22, 2011
Still River inks patent license deal with MIT
By AuntMinnie.com staff writers
Proton radiotherapy developer Still River Systems has signed a long-term licensing agreement with the Massachusetts Institute of Technology (MIT).
June 21, 2011
Previous Page
Page 228 of 440
Next Page